Cambridge, MA, May 28 — Insilico Medicine (“Insilico”), in collaboration with research partner at Huadong Medicine Company, today announced the discovery of novel small-molecule inhibitors that ...
A new review in Genes and Diseases explores the central role of MYC, a master regulatory protein, in the development and progression of cancer, spotlighting its potential as a multidimensional ...
Breast cancer is the most frequent malignancy among women worldwide, and all subtypes of breast cancer involve upregulation of the c-Myc gene, making it a compelling therapeutic target. G-rich regions ...
In a recent study published in the Journal of the American Chemical Society, researchers present the second-generation NTB bicyclic stereodiversified peptide library. Study: MYC-Targeting Inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback